Sorafekast

Sorafenib Tablets IP 200 mg

Enquire NOW!

Medicine*

Your Name*

Your Email*

Your Phone*

Your Country*

Message

Categories: Oncology, Oncology Orals Manufacturer

Description
Download Product PDF Attachment

Description

COMPOSITION: Each tablet contains Sorafenib 200 mg

INDICATION: SORAFEKAST is indicated for

Hepatocellular cell carcinoma that cannot be removed by surgery (Liver cancer)
Renal cell carcinoma (Kidney cancer)
Difierentiated Thyroid carcinoma (Thyroid cancer)

PACKING: 30 Tablets Bottle & 120 Tablets Bottle

Download Product PDF Attachment

Sorafekast

Download

Disclaimer: This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence-based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Any liability for patent infringement is at the buyer's risk. The website does not sell/purchase any medicine.

Sorafekast

Thank you for your enquiry. We will get back to you shortly!

Description

Sorafekast

Related products